Nasal Swab Test Can Improve Early Lung Cancer Assessment
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read MorePosted by Chris Wolski | Oct 21, 2021 | Lung Cancer |
Data supports that a noninvasive nasal swab test can help physicians more accurately assess lung cancer risk in patients with lung nodules.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Lung Cancer |
Researchers have developed novel artificial intelligence blood testing technology that detected over 90% of lung cancers from 800 samples.
Read MorePosted by Chris Wolski | Aug 20, 2021 | Lung Cancer |
Delfi Diagnostics’s lung cancer screening technology, which analyzes genome-wide cell-free DNA fragmentation profiles, detected 90% of cases.
Read MorePosted by Melanie Hamilton-Basich | May 24, 2021 | Lung Cancer |
The new findings show the Percepta Nasal Swab, a first-of-its-kind genomic test, accurately classifies lung cancer risk in current or former smokers with lung nodules so that those with benign nodules may safely avoid unnecessary additional procedures.
Read MorePosted by Laurie Bonner | Jan 27, 2021 | Lung Cancer, Molecular Diagnostics |
Study to focus on using saliva in the analysis of cell-free circulating tumor DNA to accurately and noninvasively detect non-small cell lung cancer.
Read More